Alkem Labs sees Rs 930 crore block deal as promoter family entities pare stake; Goldman, Morgan Stanley among key buyers

Shares of Alkem Laboratories witnessed block deals worth about Rs 930 crore on Tuesday, with promoter family entities selling shares to a clutch of domestic mutual funds and foreign institutional investors. According to NSE block deal data, a total of 17.88 lakh shares changed hands at Rs 5,200 apiece. The transaction value works out to…

Read Full News

Former Ripple exec Greg Kidd buys Know Labs with Bitcoin

Goldeneye 1995 LLC, an affiliate of fintech investor and Ripple’s former chief risk officer, Greg Kidd, is buying a controlling interest in health monitoring company Know Labs using 1,000 Bitcoin and some extra cash.  U.S.-based medical device company Know Labs develops non-invasive health monitoring tools using radio-microwave spectroscopy to help identify and measure molecules inside…

Read Full News

AION Labs launches CombinAble.AI to design antibodies for therapeutic development

Israel-based AION Labs, an AI-enabled drug discovery partnership between global pharma and tech companies, announced the launch of a new startup company CombineAble.AI, which will speed up the development of therapeutics by addressing challenges associated with antibody design.  CombinAble.AI was formed following an AION Labs startup challenge aimed at developing an AI-based solution for therapeutic…

Read Full News